siRNA intervention inhibiting viral replication and delivery strategies for treating herpes simplex viral infection
Author:
Funder
Manipal McGill Center for Infectious Disease
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Virology
Link
http://link.springer.com/content/pdf/10.1007/s13337-018-00508-z.pdf
Reference36 articles.
1. Blondeau C, Pelchen-Matthews A, Mlcochova P, Marsh M, Milne R, Towers G. Tetherin restricts herpes simplex virus 1 and Is antagonized by glycoprotein M. J Virol. 2013;87(24):13124–33.
2. Chouljenko D, Kim I, Chouljenko V, Subramanian R, Walker J, Kousoulas K. Functional hierarchy of herpes simplex virus 1 viral glycoproteins in cytoplasmic virion envelopment and egress. J Virol. 2012;86(8):4262–70.
3. Crump CM, Bruun B, Bell S, Pomeranz LE, Minson T, Browne HM. Alpha herpesvirus glycoprotein M causes the relocalization of plasma membrane proteins. J Gen Virol. 2004;85:3517–27.
4. da Silva A, Lopes JF, Paula VS. RNA interference inhibits herpes simplex virus type 1 isolated from saliva samples and mucocutaneous lesions. Braz J Infect Dis. 2014;18(4):441–4.
5. da Silva A, Raposo JV, Pereira TC, Pinto MA, de Paula VS. Effects of RNA interference therapy against herpes simplex virus type 1 encephalitis. Antivir Ther. 2016;20(3):225–35.
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Therapeutic Nucleic Acids Against Herpes Simplex Viruses (A Review);Russian Journal of Bioorganic Chemistry;2023-11
2. Therapeutic Nucleic Acids against Herpes Simplex Viruses;Биоорганическая химия;2023-11-01
3. Immortalization Reversibility in the Context of Cell Therapy Biosafety;International Journal of Molecular Sciences;2023-04-23
4. Liposomal siRNA Formulations for the Treatment of Herpes Simplex Virus-1: In Vitro Characterization of Physicochemical Properties and Activity, and In Vivo Biodistribution and Toxicity Studies;Pharmaceutics;2022-03-13
5. Potential of cell-penetrating peptides (CPPs) in delivery of antiviral therapeutics and vaccines;European Journal of Pharmaceutical Sciences;2022-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3